© 2026 Sinochem Nanjing Corporation,
All Right Reserved
Sodium paeonol sulfonate traces its roots back to the growing interest in natural products chemistry, particularly in traditional Chinese medicine research circles. Lab technicians began isolating paeonol from the root bark of peonies and soon realized its promise as an anti-inflammatory and antibacterial agent. The push for water-soluble derivatives brought sulfonation to the table. Chemical engineers hustled to develop scalable routes, gradually fine-tuning reactions to get reproducible purity while still maintaining stability for storage and handling. Public records and patent filings from the late 1990s and early 2000s show a steady climb in both academic papers and industrial applications.
At its core, sodium paeonol sulfonate is a modified form of paeonol, optimized for aqueous formulations where straight paeonol just doesn’t dissolve well enough. Chemists add a sulfonic acid group and then neutralize it to the sodium salt, delivering a pale-to-white powder that holds its own in water-based systems. This change opens the door for greater flexibility in pharmaceutical formulations and even nutraceutical options. As someone who’s worked in R&D, the ease of weighing and blending this salt compared to the oily raw paeonol makes sample prep a lot less of a headache.
This compound typically shows up as a fine, free-flowing powder with a slightly bitter taste and a faint, characteristic scent. Its solubility in water is the big selling point—whereas pure paeonol has major limits, here you can get clear solutions at room temperature. The melting point sits well above normal bench conditions, so there’s no fear of it going soft. Chemically speaking, that sulfonate group means improved stability in pH ranges common to most drugs and cosmetics. The sodium ion helps guard against moisture uptake compared with other salt forms.
Industry expectations demand a purity above 98%, with heavy metal contamination checked to trace levels given medical interest in this compound. Typical spec sheets will lay out limits on moisture, ash content, and identifiable impurities using liquid chromatography. Product labels by law require full chemical names, batch codes, and expiry details, plus GHS-compliant pictograms for safe handling. Most vendors also print out the chemical structure for institutions that process these chemicals through internal review. I’ve seen that clear labeling can streamline auditing and avoid regulatory headaches down the road.
Most commercial production starts by extracting paeonol from peony root. The paeonol goes through a controlled sulfonation using sulfonating agents—often sulfur trioxide or chlorosulfonic acid. Temperature tracking and rate of reagent addition play key roles here; run too hot and you end up with degraded byproducts, too slow and your yield tanks. Quenching and neutralization follow, leading to sodium paeonol sulfonate as a precipitate. The crude material gets re-dissolved and recrystallized, which helps lift out colored impurities. As someone who’s set up kilo-scale runs, I’ve learned that filtration and pH adjustments can make or break batch reproducibility.
That sulfonic acid group isn’t just there for water solubility—it opens up new chemistry. The sulfonate handles oxidizing and reducing environments with decent stability, as confirmed by stability studies in various buffer systems. It can undergo further modifications, allowing tailored derivatives for special pharmaceutical applications. Studies have examined how the compound holds up under UV and heat; so far, most samples show solid resilience. In storage, common antioxidants help prevent slow oxidation of the aromatic system.
Synonyms can drive you nuts in literature searches. On records, you might spot “sodium paeonol-4-sulfonate,” “paeonol sulfonic acid sodium salt,” or even just “SPS.” Brand names on pharmacy shelves, if it goes that route, tend to be short—marketed names often end in “-sol” to emphasize solubility if targeted at clinics or supplement outlets. Sorting between synonyms in scientific indexing services cuts down research rabbit holes and duplicate order errors.
Working with sodium paeonol sulfonate doesn’t require a hazmat suit, but labs still take dust control and proper glove use seriously. Material safety data sheets list it as low-to-moderate risk by ingestion or inhalation, though eye and skin contact will cause irritation if you’re not careful. I make a point of keeping extraction hoods live when weighing out larger batches. Regulatory guidance in China, Europe, and the United States sets limits for allowable residue levels in finished drugs—contamination above thresholds means failed lots and recall risk.
If you walk the halls of a cosmetics manufacturer or pharmaceutical formulation lab, you’ll spot this material in action. Its anti-inflammatory profile attracts formulators making skin care serums aimed at redness and irritation. In oral tablets and capsules, the sodium salt delivers its active principle while totally sidestepping dissolvability headaches. Some topical gels pitch it for wound healing thanks to mild antimicrobial properties, though evidence on that is mixed and still rolling in. Veterinarians watch this space for animal-care blends—solubility again opens up dosing options for livestock and pets alike.
Academics stay busy mapping the bioactivity of sodium paeonol sulfonate, hunting for leads in anti-allergic and neuroprotective roles. I’ve seen grant-funded teams use cell line models to tease out the precise anti-inflammatory mechanism, suggesting it tunes down key cytokine pathways. Clinical pipeline updates so far point to interest in both acute treatments and long-term management of skin and oral diseases. Pharma startups tinker with delivery tech to stretch absorption windows and enhance bioavailability without boosting toxicity.
No one wants a promising compound that flunks safety, so toxicity tests command priority. Early mouse studies from trusted toxicology labs report a high threshold for acute effects at typical dosing levels. Researchers track liver enzyme markers and organ weights over extended use, scanning for sneaky signals of chronic damage. Most labs agree it clears animal studies with better margins than untreated paeonol and showing a more favorable GI tolerance profile. Regulatory agencies still ask for more reproductive toxicity and mutagenicity data, so developers submit ongoing updates as projects advance.
As consumer demand for plant-based actives climbs, sodium paeonol sulfonate earns more scrutiny from both buyers and regulators. Improved green chemistry routes could cut waste in the production cycle—something both executives and eco-conscious end users ask about before purchase orders get signed. Biomarker studies in human volunteers might unlock new indications, possibly as adjuncts to steroids or antibiotics in hard-to-treat wounds. Collaborations grow between research universities and mid-sized pharmaceutical startups, betting that regulatory hurdles will bend as stronger clinical evidence lands. I’ve worked with project managers who see this compound as a bridge—connecting traditional medicine insights with the rigor modern drug development demands.
Anyone who’s spent time thumbing through ingredient lists in a pharmacy or flipping over the back of herbal supplement boxes might wonder about names like Sodium Paeonol Sulfonate. Rarely do doctors or pharmacists chat about it in daily conversation, but this compound finds its way into many prescriptions—especially in advanced healthcare settings across parts of Asia, and more research is trickling into global markets.
The heart and blood vessels keep life moving, and too often, they take a beating from poor lifestyle choices, family history, or chronic inflammation. Sodium Paeonol Sulfonate offers an interesting approach for problems tied to blood circulation. It’s no secret that modern medicine looks for molecules that can provide anti-inflammatory relief and support blood vessels under stress. Sodium Paeonol Sulfonate, synthesized from paeonol, takes aim at exactly that.
Clinicians and pharmacologists have studied how it might help improve blood flow, keep clots in check, and protect tissues at risk during events like stroke or chronic vascular disease. Patients with angina or threatened by ischemia have seen sodium paeonol sulfonate included in injectable form in certain hospital settings, particularly in China, as part of broader acute-care plans. The molecule appears to reduce oxidative stress and work against the cascade leading to tissue damage in deprived blood flow. Of course, no pharmacy shelf cure exists, but early clinical reports suggest fewer complications and better recovery with its use.
Inflammation always seems to be lurking—whether it's acute swelling after an injury or persistent, low-grade inflammation in chronic disease. In my own work shadowing practitioners in traditional Chinese medicine clinics, I saw formulas containing paeonol and its derivatives prescribed for joint pain, mild fevers, and even nasty sinus discomforts. Sodium paeonol sulfonate sits at the front of the pack for its more predictable absorption and metabolic profile.
Published lab results show it targets cellular messengers involved in swelling and inflammatory flare-ups, offering relief that goes beyond just numbing pain. For patients who complain about stomach upset or allergic reactions from NSAIDs, compounds like this can sometimes offer real alternatives—though always under medical supervision.
Skepticism keeps science honest, and sodium paeonol sulfonate hasn’t gained global approval for every possible condition. Much of the data comes from small-scale clinical trials or hospital-based practice reports. Regulatory agencies in the US and Europe still call for lengthy, robust studies before recommending it as standard care. For now, most clinical applications occur in specialized cardiovascular or neurological wards, often alongside mainstream drugs.
Doctors treating chronic pain, stubborn vascular problems, or unexplained inflammation ask for proof, not just tradition. More patients expect to see published results, ethical oversight, and transparent sourcing. Luckily, researchers are responding—with new trials measuring safety, best delivery methods, and how it works at the chemical level.
Patients deserve honesty about what goes into treatment. For sodium paeonol sulfonate, the next steps mean clearer labeling, detailed patient information, and more follow-up data on long-term outcomes. Health professionals and consumers alike want clear sources, traceable production, and monitored side effects. With every scientific breakthrough comes a responsibility to keep safety and transparency at the core of healthcare. That’s as true for sodium paeonol sulfonate as it is for any emerging therapy.
Sodium paeonol sulfonate comes from paeonol, a compound found in peony roots. Traditional Chinese medicine has leaned on paeonol for ages, often for inflammation or pain. Chemists tweak paeonol into sodium paeonol sulfonate, which dissolves better in water, so it fits into creams, gels, and sometimes injections. Drugmakers in a few countries add it into formulas for injuries or skin irritation.
Most public studies on sodium paeonol sulfonate are small, usually done on animals or cell cultures. Some research teams looked at immune cells exposed to sodium paeonol sulfonate. They didn’t flag sudden cell damage or odd genetic shifts at regular doses. A Chinese pharmacology journal published findings where mice given sodium paeonol sulfonate by injection didn’t show short-term toxic effects. Even with injections on several days, weight change and blood tests fell in normal ranges for those lab animals.
Doctors in China sometimes prescribe sodium paeonol sulfonate formulations for pain and swelling. Medical reports going back several years rarely mention severe side effects. Short-term rashes or mild itching came up once in a while, but nothing life-threatening. Still, these are mostly drawn from hospital charts, not from large, public data sets.
The evidence gives some comfort, but there’s a difference between “probably safe” and “proven safe for everyone.” Trials in mice and rats don’t tell us everything about humans. Long-term effects are missing, too—no one has tracked folks for years after using this ingredient. People allergic to paeonol or sulfonate groups might respond differently, and rare side effects might slip under the radar without enough users in the data.
Health regulators in the United States, Europe, and much of the world have not cleared sodium paeonol sulfonate for general use. Literature from regulatory agencies says there’s not enough high-quality safety data to give it a blanket approval for sale. China’s National Medical Products Administration, on the other hand, lists certain sodium paeonol sulfonate products for controlled use under prescription.
My experience with traditional remedies leaves me cautious. Someone in my extended family tried a topical cream that included a paeonol extract, but the doctor warned us not to slather on too much or use it for longer than directed. Even when a plant compound sounds gentle, there’s always a risk if manufacturers cut corners or skip clinical trials. Knowing where a product comes from and reading up on published medical findings—especially in peer-reviewed journals—makes a difference.
People wondering if they should use a product with sodium paeonol sulfonate ought to check with a licensed healthcare provider first. If no doctor is available, searching reputable medical websites or published journals gives a stronger foundation than going off marketing flyers. For manufacturers, turning raw animal data into robust clinical studies means everyone can make smarter choices. Clear regulations and stronger labels will also help, spelling out exactly who should beware. My main takeaway: if trusted sources haven’t tested or approved an ingredient for your problem, don’t use it until they do.
Sodium paeonol sulfonate shows up mostly in some newer skin treatments and anti-inflammatory products. With so many people growing cautious about what goes into their bodies and onto their skin, talk about its safety makes sense. People trust brands and medical professionals because they expect someone to look after their health interests before introducing new ingredients. If doctors or consumers have questions about risks, there’s no shame in pressing for straight answers. Trust grows through real-world experiences and open dialogue.
Most research on sodium paeonol sulfonate rises out of studies in China, where paeonol, from peony root, gets attention for its anti-inflammatory and antioxidant properties. After modifying it into sodium paeonol sulfonate, chemists aim for better solubility and stability. Though early findings look promising, side effects call for a careful eye, especially for something new.
Some common complaints that users mention include slight redness or itching on the skin after topical use. Rare cases involve swelling or a rash, which points to possible allergic reactions. These reactions usually show up shortly after contact, so it isn’t too hard to connect the dots. Ingested forms, used in a few experimental settings, have led to mild digestive discomfort—think nausea or an unsettled stomach. No reports tie sodium paeonol sulfonate to severe organ damage or life-threatening reactions so far, but no one should bet their health on limited evidence.
Stories from real people often outpace published trials. More clinics need to record and share their experiences. As it stands, evidence on long-term use or interactions with other drugs is thin. Most current trials cover weeks—not months or years. People with sensitive skin, allergies to peony plants, or autoimmune conditions seem more likely to notice problems. The absence of strong regulations in some markets also means products may skip full reporting.
Researchers could do everyone a favor by running larger, longer studies. Just because something is new and plant-based doesn't mean it’s risk-free. Pharmacists and clinicians should press manufacturers for full ingredient lists and batch data. Governments and drug agencies should create clearer reporting channels for unexpected side effects, making it easier for patterns to emerge.
For the everyday person, nobody wants to become a chemistry experiment in the bathroom or pharmacy aisle. Do a quick patch test and watch for strange reactions in the first few days. If something looks off, talk to a doctor or pharmacist. Avoid using the product on broken skin or together with strong acids, steroids, or other unfamiliar substances.
Science flourishes on real cases, not just theory. If more users and clinics confirm benefits without major side effects, sodium paeonol sulfonate could earn a spot in mainstream medicine. Sitting on risks or brushing off complaints stops that progress cold. A single voice sharing an experience—good or bad—pushes understanding further than another lab report. Responsible brands encourage honest feedback, publish side effect rates, and fund long-term studies, fostering real credibility.
Chemicals sitting on a lab shelf don’t always make headlines. Still, neglecting proper storage has tripped up more than one research lab and caused problems nobody wants. Sodium Paeonol Sulfonate, often used in pharmaceutical studies and sometimes in plant extracts, is no exception. Keeping this compound stable means more than just dusting off the jar or letting it sit under the fume hood.
Sodium Paeonol Sulfonate comes as a white to off-white powder or fine crystals. In my years at an academic lab, I learned pretty fast that ignoring the unique quirks of each chemical invites trouble. This one tends to absorb moisture from the air. Leave the cap off too long and it’ll clump, cake, or—worse—start pulling in water, making weighing and dosing unreliable. If you have ever measured out clumpy reagents, you know that accuracy goes right out the window.
Heat, humidity, and exposure to light aren’t small details either. Every chemical has its own personality. Long-term exposure to light can lead to slight decomposition, and chemicals that break down start to pose new risks. You end up with misleading results, ruined experiments, and sometimes dangerous byproducts nobody bargained for.
So what does careful storage look like? Ours used to follow a simple rule: cool, dry, and dark. For Sodium Paeonol Sulfonate, that means a tightly sealed container kept in a dry cupboard, away from sunlight, at regular indoor temperature—below 25°C works well. If you work in a tropical place where humidity never quits, investing in a good desiccator will save you more times than you think. Room temperature sounds fine on paper, but rooms can get surprisingly warm. A basic thermometer near your chemical cupboard gives a reality check.
Mix-ups often happen when containers lose labels or get left open. Even one missed cap can turn an expensive chemical into an unidentifiable mess. In our lab, sharpies and dated masking tape were standard issue; everyone knew exactly what was inside and when it arrived. For bottles that arrived with silica gel packets, nobody tossed them. Those little bags pulled their weight by keeping moisture in check.
Good storage habits go far beyond regulatory checklists. The cost of accidental exposure or mishandling is higher than most expect. Spills mean cleanup, health risks, and sometimes ruined equipment. Poorly stored chemicals may affect patient safety if the material ends up in a drug supply chain. The World Health Organization and FDA have strict storage guidelines for a reason: public trust and safety lie in these habits.
Many labs now keep digital logs of inventory and expiry dates, reducing surprises and wasted stock. In my experience, simple checklists posted right inside the door work just as well. Regularly clearing out expired chemicals prevents surprises and frees up shelf space—something no scientist ever has enough of.
No chemical is immune to poor storage. Being mindful with Sodium Paeonol Sulfonate doesn’t demand fancy equipment, just attention and some basic discipline. Lab work always comes down to the details, and consistent storage habits make every project safer and more reliable. It’s a small investment that pays off in fewer headaches and safer science all around.
Sodium paeonol sulfonate isn’t a name most folks run into at the pharmacy. This synthetic derivative of paeonol gets its roots from traditional Chinese medicine and often finds its purpose in treating inflammation and allergic reactions. Even though less common in most Western hospitals, it makes its rounds in several countries for its ability to ease pain, support circulation, and fight off unwanted swelling in the body. The question on people’s minds often circles back to one thing: how much should a person actually take?
Doctors usually give sodium paeonol sulfonate through an intravenous drip or by direct injection. Adults often receive 0.2 to 0.5 grams dissolved in 250 to 500 mL of a glucose or saline solution, taken once a day. Most clinical guidelines suggest sticking with these numbers, but treatment might last from 7 up to 14 days, depending on how the patient responds. In my own time reading medical literature, few drugs show as much reliance on a doctor's judgment for dosing. Some patients, especially older adults or those with kidney issues, require careful adjustment to avoid side effects.
The main concern with getting the dose right circles around safety. The body processes paeonol sulfonate through the liver and kidneys. Overdosing can stress these organs, raise the risk of side effects like rashes, allergic reactions, or stomach upset. For kids or pregnant women, doctors tend to tread even more carefully, usually recommending a lower dose or sometimes picking another medicine entirely. It’s not just about the number on the vial—it’s about matching the dose with the person’s unique health profile.
No one wants to swing blindly when treating inflammation, especially not with a compound that the average person can’t find over the counter. The strength of sodium paeonol sulfonate lies in its double-edged nature: powerful enough to help, but demanding respect for its risks. Taking more than recommended can bring headaches, digestive trouble, or, in rare cases, problems with heart rhythm. For someone healthy, the standard range works. The person with another illness, or on other prescriptions, needs more attention. I’ve come across reports where skipping lab checks led to adverse events; blood tests before and during use help keep risks in check.
Too often, patients trust that the healthcare system handles all the details. If you ask your doctor or pharmacist for dosing specifics, you take control of your treatment. Medical journals from China point out that doctors found success by tailoring sodium paeonol sulfonate dose based on lab results and regular monitoring. In clinics where resources run thin, the situation grows riskier, so open conversation and following up with bloodwork make a real difference. Pharmaceutical companies also carry responsibility. They must share clear, updated dosing details in every package leaflet and online, in plain language—not just technical tables no one reads.
Sodium paeonol sulfonate serves a clear purpose, but success rides on using the right amount in the right person. Trust builds between care teams and patients when there’s room to ask questions about dosing, adjustments, or alternatives. Reading up on treatments, discussing with knowledgeable doctors, and weighing risks versus benefits—these actions help protect health and foster better results. Treatments rooted in centuries-old wisdom still need modern checks and balances.
| Names | |
| Other names |
Sodium Paeonosidum Sulfonate Sodium paeonolsulfonate |
| Pronunciation | /ˈsəʊdiəm piːˈɒnɒl ˈsʌlfəneɪt/ |
| Identifiers | |
| CAS Number | 62198-18-7 |
| Beilstein Reference | 2693205 |
| ChEBI | CHEBI:132731 |
| ChEMBL | CHEMBL2103833 |
| ChemSpider | 22587522 |
| DrugBank | DB13251 |
| ECHA InfoCard | 15e60d11-9d5a-4bde-abcd-df5567a6f0ca |
| EC Number | EC 620-176-8 |
| Gmelin Reference | 109129 |
| KEGG | C16429 |
| MeSH | D000072633 |
| PubChem CID | 11954360 |
| RTECS number | VP2300000 |
| UNII | 208I1J6R48 |
| UN number | UN2811 |
| CompTox Dashboard (EPA) | DTXSID8021883 |
| Properties | |
| Chemical formula | C9H9NaO5S |
| Molar mass | 380.36 g/mol |
| Appearance | White or almost white crystalline powder |
| Odor | Odorless |
| Density | 1.49 g/cm³ |
| Solubility in water | Soluble in water |
| log P | -2.0 |
| Vapor pressure | Negligible |
| Acidity (pKa) | pKa ≈ 9.5 |
| Basicity (pKb) | 12.98 |
| Refractive index (nD) | 1.523 |
| Viscosity | Viscosity: 1.029 mPa·s (25°C, 10% solution) |
| Dipole moment | 2.87 D |
| Thermochemistry | |
| Std molar entropy (S⦵298) | 416.2 J·mol⁻¹·K⁻¹ |
| Pharmacology | |
| ATC code | C05AX12 |
| Hazards | |
| Main hazards | Harmful if swallowed, causes skin and eye irritation. |
| GHS labelling | GHS07, GHS09 |
| Pictograms | GHS07 |
| Signal word | Warning |
| Hazard statements | H315: Causes skin irritation. H319: Causes serious eye irritation. H335: May cause respiratory irritation. |
| Precautionary statements | IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. If eye irritation persists: Get medical advice/attention. IF ON SKIN: Wash with plenty of water. |
| NFPA 704 (fire diamond) | 1-2-0 |
| LD50 (median dose) | LD50 (median dose): Mouse intravenous LD50=437mg/kg |
| NIOSH | Not listed |
| PEL (Permissible) | PEL (Permissible Exposure Limit) for Sodium Paeonol Sulfonate: Not established |
| REL (Recommended) | 0.8% |
| Related compounds | |
| Related compounds |
Paeonol Paeoniflorin Paeonol Oxime Sodium Paeoniflorin Methyl Paeonol Ethyl Paeonol Paeonolide Sulfonated Paeonol |
